Naturo Indiabull FY26 Annual Report: Zero Revenue, Loss

Company snapshot and what the filing signals

Naturo Indiabull Ltd is a micro-cap company listed on the BSE (543579). In its latest disclosures around the FY26 annual report (dated 10 September 2026), the headline is a sharp deterioration in operating activity. The company reported revenue from operations of ₹0.00 crore for FY26, compared with ₹2.05 crore in FY25. The filing also points to audit-level concerns that go beyond performance, covering compliance, systems, and the ability to verify certain assets and balances. For investors tracking small-cap and micro-cap counters, this combination often becomes the main driver of risk perception. The disclosures also include half-yearly data through September 2025, which shows operating losses during that period.

FY26 performance: revenue falls to zero

The key operational datapoint is the company’s FY26 revenue from operations at ₹0.00 crore. This is a stark reversal from FY25 revenue from operations of ₹2.05 crore, as stated in the disclosure. In the longer annual series (Figures in ₹ crore), the company’s sales line also shows ₹0.00 crore for the period ending March 2026, versus ₹2.05 crore for March 2025. Costs did not fall to zero, with the annual series showing expenses of ₹0.29 crore for March 2026. As a result, operating profit remained negative in that annual table, at -₹0.29 crore for March 2026.

Net result: reported loss and conflicting extracts

The FY26 summary in the disclosure states the company registered a net loss of ₹0.82 crore in FY26. The same summary also notes FY25 net loss of ₹1.30 crore. Separately, the provided extracts from profit-and-loss tables in the disclosure include references to “nettoresultat” of -₹8.21 for the full year and an operating result of -₹7.36, along with quarterly metrics such as net income of -₹6.25 and operating income of -₹5.83. These figures appear in the reproduced tables and narrative snippets, but the disclosure also explicitly highlights the FY26 net loss as ₹0.82 crore. Investors typically treat such inconsistencies as an additional disclosure-quality risk until reconciled by the company.

Half-yearly trend: sharp swing by September 2025

Half-yearly results (Figures in ₹ crore) show sales of ₹13.39 crore for September 2024, dropping to ₹0.00 crore for September 2025. Expenses moved from ₹12.84 crore (September 2024) to ₹0.16 crore (September 2025). Operating profit turned negative at -₹0.16 crore in September 2025, from a positive ₹0.55 crore in September 2024. Profit before tax similarly shifted to -₹0.20 crore (September 2025) from ₹0.49 crore (September 2024). Net profit in the half-yearly table was -₹0.20 crore for September 2025, compared with ₹0.49 crore for September 2024. EPS for September 2025 was shown at -₹0.11 versus ₹0.26 a year earlier.

Auditor’s qualified opinion: what was flagged

The statutory auditor issued a qualified opinion on the FY26 financial statements. The disclosure attributes this to regulatory contraventions, issues with accounting software, and significant overdue statutory dues. A qualified opinion signals that the auditor believes certain matters are materially misstated or could not be sufficiently verified, while still issuing an opinion rather than an adverse opinion or disclaimer. For a micro-cap, such remarks can matter as much as the profit-and-loss trend because they influence how investors assess the reliability of reported numbers and controls.

Overdue statutory dues: income tax and TDS/TCS

The disclosure lists specific overdue items outstanding for more than six months. Outstanding income tax is reported at ₹1.28 crore. Outstanding TDS/TCS is reported at ₹0.11 crore. These amounts are presented as overdue statutory dues in the filing, and they sit alongside the auditor’s concerns. Overdues of this type can create cash-flow pressure and may restrict operational flexibility if not resolved.

Asset recoverability: loans, advances, and inventory not confirmed

A major red flag in the disclosure is that recoverability of significant assets remains unconfirmed. Short-term loans and advances are shown at ₹54.58 crore with recoverability unconfirmed. Inventory is reported at ₹10.65 crore, with existence and valuation unconfirmed. These statements matter because they go to the balance sheet’s credibility and the extent to which reported assets can be converted into cash or used in operations. When such items are not confirmed, investors generally look for subsequent clarifications, management explanations, or audit note updates in later filings.

Key numbers at a glance (all ₹ crore unless stated)

Corporate calendar: audited results meetings referenced

The disclosure also includes meeting dates linked to audited results. A meeting dated 30-May-25 is listed for audited results. Another entry dated 11-Jun-24 is marked as audited results (revised), with an additional 05-Jun-24 revised audited results entry. These dates provide context on when audited financial information was considered or revised.

Market impact: what investors typically watch next

From the disclosed data, the most immediate market-relevant factors are the move to zero operating revenue and the qualified audit opinion. The presence of overdue statutory dues and unverified assets adds to the risk profile. The point-in-time share price of ₹3.15 (as of 19 February 2026) indicates the stock’s penny-level trading range at that time, where liquidity and price volatility can be elevated. Any subsequent exchange filings that clarify audit observations, provide evidence on asset recoverability, or show a restart of operations are likely to become key triggers for investor attention.

Analysis: why the qualified opinion and verification gaps matter

A revenue decline can sometimes be cyclical, but audit qualifications tied to compliance and accounting systems generally require direct remediation. The disclosure’s emphasis on accounting software issues suggests process weaknesses that can affect everything from invoice recognition to statutory reporting. Large short-term loans and advances (₹54.58 crore) and inventory (₹10.65 crore) that are not confirmed raise the question of how quickly the company can demonstrate balance-sheet strength. For micro-cap companies, the combination of weak operations and audit remarks can affect access to working capital, vendor terms, and stakeholder confidence.

Conclusion

Naturo Indiabull’s FY26 disclosure highlights a year of zero revenue from operations, a reported net loss, and a qualified audit opinion citing compliance and reporting concerns. The filing also flags overdue statutory dues and unverified loans, advances, and inventory balances. Investors tracking the stock will likely focus on follow-up disclosures that address audit qualifications, confirm recoverability of key assets, and provide evidence of operational activity returning.